Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Safety and Pharmacology Study of SNX-5422 in Subjects With Resistant Lung Adenocarcinoma

This study has been completed.
Information provided by (Responsible Party):
Esanex Inc. Identifier:
First received: May 4, 2013
Last updated: August 15, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2016
  Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)